INTT vs AEHR vs COHU vs ONTO vs FORM

For growth investors, Cohu, Inc.

(COHU) is the stronger pick with 12. 7% revenue growth year-over-year, versus -12. 9% for inTEST Corporation (INTT). Onto Innovation Inc. (ONTO) offers the better valuation at 102. 4x trailing P/E (39. 9x forward), making it the more compelling value choice. Analysts rate inTEST Corporation (INTT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Onto Innovation Inc.

(ONTO) is the cheapest at 102. 4x versus FormFactor, Inc. at 214. 3x. On forward P/E, inTEST Corporation is actually cheaper at 37. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +42.

2%, compared to +35. 5% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: AEHR returned +75. 0% versus INTT's +343. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), inTEST Corporation (INTT) is the lower-risk stock at 1.

25β versus Aehr Test Systems's 4. 86β — meaning AEHR is approximately 288% more volatile than INTT relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 46% for Cohu, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Cohu, Inc.

(COHU) is pulling ahead at 12. 7% versus -12. 9% for inTEST Corporation (INTT). On earnings-per-share growth, the picture is similar: Aehr Test Systems grew EPS 0. 0% year-over-year, compared to -187. 5% for inTEST Corporation. Over a 3-year CAGR, AEHR leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Onto Innovation Inc.

(ONTO) is the more profitable company, earning 13. 6% net margin versus -16. 4% for Cohu, Inc. — meaning it keeps 13. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ONTO leads at 13. 2% versus -13. 3% for COHU. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, inTEST Corporation (INTT) trades at 37.

0x forward P/E versus 85. 0x for Cohu, Inc. — 48. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ONTO: 16. 5% to $331. 67.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, FormFactor, Inc.

(FORM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1997% 10Y return). Aehr Test Systems (AEHR) carries a higher beta of 4. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FORM: +1997%, AEHR: +75. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.